Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
The Journal of Biological Chemistry
|
April 10, 2022
Spinning sugars in antigen biosynthesis: characterization of the Coxiella burnetii and Streptomyces griseus TDP-sugar epimerases
Alice R Cross, Sumita Roy, Mirella Vivoli Vega, et al.
The Pediatric Infectious Disease Journal
|
June 13, 2015
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials
Timo Vesikari, Jan Hendrik Richardus, Johan Berglund, et al.
Blood Cancer Journal
|
October 21, 2024
Results from Arm A of Phase 1/2 DREAMM-6 trial: belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
Rakesh Popat, Bradley Augustson, Mercedes Gironella, et al.
The Journal of Clinical Investigation
|
March 9, 2011
IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function
Jordan S Orange, Sumita Roy-Ghanta, Emily M Mace, et al.
Communications Biology
|
April 21, 2022
Nutrient and salt depletion synergistically boosts glucose metabolism in individual Escherichia coli cells
Georgina Glover, Margaritis Voliotis, Urszula Łapińska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2021
A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Debashis Sarker, Nancy A Dawson, Ana M Aparicio, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 15, 2026
Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma Who Have Normal and Varying Degrees of Impaired Renal Function
Xi Chen, Shawn Hakim, Yi Ting Kayla Lien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 2, 2026
Efficacy and Safety of Belantamab Mafodotin with Bortezomib Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: the DREAMM-6 Arm B Trial
Rakesh Popat, Bradley Augustson, Paul Cannell, et al.
Vaccine
|
May 25, 2017
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants
Nicola P Klein, Remon Abu-Elyazeed, Matthew Cornish, et al.
Virulence
|
January 22, 2025
Lactic acid in the vaginal milieu modulates the <i>Candida</i>-host interaction
Diletta Rosati, Marisa Valentine, Mariolina Bruno, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
The Journal of Biological Chemistry
|
April 10, 2022
Spinning sugars in antigen biosynthesis: characterization of the Coxiella burnetii and Streptomyces griseus TDP-sugar epimerases
Alice R Cross, Sumita Roy, Mirella Vivoli Vega, et al.
The Pediatric Infectious Disease Journal
|
June 13, 2015
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials
Timo Vesikari, Jan Hendrik Richardus, Johan Berglund, et al.
Blood Cancer Journal
|
October 21, 2024
Results from Arm A of Phase 1/2 DREAMM-6 trial: belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
Rakesh Popat, Bradley Augustson, Mercedes Gironella, et al.
The Journal of Clinical Investigation
|
March 9, 2011
IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function
Jordan S Orange, Sumita Roy-Ghanta, Emily M Mace, et al.
Communications Biology
|
April 21, 2022
Nutrient and salt depletion synergistically boosts glucose metabolism in individual Escherichia coli cells
Georgina Glover, Margaritis Voliotis, Urszula Łapińska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2021
A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Debashis Sarker, Nancy A Dawson, Ana M Aparicio, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 15, 2026
Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma Who Have Normal and Varying Degrees of Impaired Renal Function
Xi Chen, Shawn Hakim, Yi Ting Kayla Lien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 2, 2026
Efficacy and Safety of Belantamab Mafodotin with Bortezomib Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: the DREAMM-6 Arm B Trial
Rakesh Popat, Bradley Augustson, Paul Cannell, et al.
Vaccine
|
May 25, 2017
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants
Nicola P Klein, Remon Abu-Elyazeed, Matthew Cornish, et al.
Virulence
|
January 22, 2025
Lactic acid in the vaginal milieu modulates the <i>Candida</i>-host interaction
Diletta Rosati, Marisa Valentine, Mariolina Bruno, et al.
Page
of 6